⌘K

Login Start Free

Home/Filings/4/0001104659-21-123271

4//SEC Filing

KURLAND FRED 4

Accession 0001104659-21-123271

CIK 0001614067other

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 6:43 PM ET

Size

5.2 KB

Accession

0001104659-21-123271

Insider Transaction Report

Form 4

Period: 2021-10-04

Aridis Pharmaceuticals, Inc.ARDS

Chief Financial Officer

Transactions

Award
Stock Options
2021-10-04+20,000→ 74,575 total
Exercise: $3.60Exp: 2031-10-04→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The stock options vest in equal installments over 48 months, beginning on October 4, 2021.

Documents

1 file

4
tm2129291-4_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1

filerCIK 0001267273

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 6:43 PM ET
Size: 5.2 KB

View on SEC.gov